Brief: Eurobio Scientific H1 Core Business Sales At +37%

Eurobio Scientific SA

24/07/2023 17:56

July 24 (Reuters) - Eurobio Scientific SA  ALERS.PA :
    * ACCELERATION OF STRATEGIC DEPLOYMENT  IN THE FIRST HALF OF
2023
    * STRONG GROWTH IN HALF-YEAR CORE BUSINESS SALES AT +37%
    * IN 1ST HALF OF 2023, EUROBIO SCIENTIFIC POSTED SALES OF
€59.1M
IN ITS CORE BUSINESS
    * ACTIVITIES RELATED TO COVID DETECTION ARE NOW
INSIGNIFICANT AND
INTEGRATED INTO THE GROUP'S CORE BUSINESS

Source text for Eikon:  ID:nGNEb6p0jP 
Further company coverage:  ALERS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))